Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

• Status: Not yet recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to use the "Removing Blood Stasis Decotion" of traditional Chinese medicine treating the acute stage of cerebral hemorrhage with stroke associated pneumonia to explore the impact of "Removing Blood Stasis Therapy" on intestinal microbial flora either within the time window from 6 to 72 hours onset.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guangzhou University of Traditional Chinese Medicine
• Collaborators: Lianjiang people's Hospital; Liaocheng People's Hospital; Shenyang Second Hospital of traditional Chinese Medicine; Shouguang people's Hospital; The third people's Hospital of Hubei Province; Zengcheng Hospital of traditional Chinese Medicine

Criteria

Inclusion Criteria:

• Greater than or equal to 18 years old while younger than 80 years old

• acute cerebral hemorrhage confirmed by brain CT scan within 6 to72 hours from onset

• GCS≥6

• Sign the informed consent form

Exclusion Criteria:

• Tests have confirmed that cerebral hemorrhage caused by brain tumor, blood diseases, cerebrovascular malformation (anomaly) or aneurysm, etc;

• patients with Severe heart, liver and renal insufficiency.

• Intolerance to traditional Chinese medicine (TCM), allergic constitution.

• patients with severe cerebral hernia in the early onset

• Compliance is poor.